Zhangzhou Pientzehuang Pharmaceutical Co (SHSE:600436) Total Equity: ¥15,756 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600436 Zhangzhou Pientzehuang Pharmaceutical Co Ltd SHSE:600436
86 GF Score
Price ¥140.02
GF Value ¥172.71
Valuation Modestly Undervalued
! 9 Warning Signs
View Full Analysis

What is Zhangzhou Pientzehuang Pharmaceutical Co Total Equity?

Zhangzhou Pientzehuang Pharmaceutical Co SHSE:600436 -4.51% 86 Total Equity is ¥15,756 Mil as of Mar. 2026. GuruFocus rates SHSE:600436 with a GF Score™ of 86/100 and a GF Value™ of ¥172.71 (Modestly Undervalued). The stock has 9 warning signs investors should review.

Zhangzhou Pientzehuang Pharmaceutical Co's total equity for the quarter that ended in Mar. 2026 was ¥15,756 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Zhangzhou Pientzehuang Pharmaceutical Co Total Equity Historical Data

* Premium members only.

The historical data trend for Zhangzhou Pientzehuang Pharmaceutical Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhangzhou Pientzehuang Pharmaceutical Co Total Equity Chart

Zhangzhou Pientzehuang Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10,137.53 11,823.94 13,920.50 14,838.74 15,088.08

Zhangzhou Pientzehuang Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15,842.43 15,196.85 15,040.67 15,088.08 15,756.29
SHSE:600436
86GF Score
Zhangzhou Pientzehuang Pharmaceutical Co Ltd SHSE:600436
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zhangzhou Pientzehuang Pharmaceutical Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Zhangzhou Pientzehuang Pharmaceutical Co's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=17560.037-2471.959
=15,088

Zhangzhou Pientzehuang Pharmaceutical Co's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=18384.671-2628.378
=15,756

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of ¥15,756 Mil mean?
Zhangzhou Pientzehuang Pharmaceutical Co (SHSE:600436) has a Total Equity of ¥15,756 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Zhangzhou Pientzehuang Pharmaceutical Co and its competitors.
Is Zhangzhou Pientzehuang Pharmaceutical Co's Total Equity too high?
Zhangzhou Pientzehuang Pharmaceutical Co's current Total Equity is ¥15,756 Mil. Overall, Zhangzhou Pientzehuang Pharmaceutical Co has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zhangzhou Pientzehuang Pharmaceutical Co's Total Equity compare to LLY and JNJ?
Zhangzhou Pientzehuang Pharmaceutical Co's Total Equity of ¥15,756 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Drug Manufacturers company?
A good Total Equity depends on the Drug Manufacturers industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Zhangzhou Pientzehuang Pharmaceutical Co and its competitors. Zhangzhou Pientzehuang Pharmaceutical Co's current Total Equity is ¥15,756 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhangzhou Pientzehuang Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Zhangzhou Pientzehuang Pharmaceutical Co (SHSE:600436) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥172.71, compared to a current price of ¥140.02 — trading 18.9% below its estimated fair value. The current Total Equity is ¥15,756 Mil. Zhangzhou Pientzehuang Pharmaceutical Co's overall GF Score™ is 86/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Zhangzhou Pientzehuang Pharmaceutical Co (SHSE:600436), the current Total Equity is ¥15,756 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zhangzhou Pientzehuang Pharmaceutical Co (SHSE:600436) Overvalued in 2026?

Based on GuruFocus' analysis, Zhangzhou Pientzehuang Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥140.02 is trading 18.9% below its estimated GF Value™ of ¥172.71. GuruFocus considers Zhangzhou Pientzehuang Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for SHSE:600436:

  • Total Equity: ¥15,756 Mil
  • GF Value™: ¥172.71 vs. price of ¥140.02 (18.9% below fair value)
  • GF Score™: 86/100 with 9 warning signs

No single metric tells the full story. See the SHSE:600436 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zhangzhou Pientzehuang Pharmaceutical Co Business Description

Address No. 1, Hupo Road, Xiangcheng District, Fujian Province, Zhangzhou, CHN, 363000
Zhangzhou Pientzehuang Pharmaceutical Co Ltd produces and sells Chinese medicines. The company's product categories include tablets, hard capsules, granules, pills (water pills, honey pills), syrups, tinctures (including external use), ointments, lozenges, decoctions, Chinese herbal medicine slices (including direct oral slices) (clean preparation); production of candy products (candy), health food products; and production of beverages (solid beverages).
86GF Score

Get the complete analysis for SHSE:600436

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥140.02
Price
¥172.71
GF Value